National Institutes of Diabetes and Digestive and Kidney Diseases; Amended Notice of Meeting, 52551-52552 [06-7435]

Download as PDF Federal Register / Vol. 71, No. 172 / Wednesday, September 6, 2006 / Notices can help diagnose or follow up on the progress of a variety of diseases, including Huntington’s Disease, olivopontocerebellar atrophy, epilepsy, schizophrenia, as well as hepatitis, cirrhosis, cholangitis, Gilbert’s diseases, muscular dystrophy, leukemia, kidney inflammation, cardiac infarction, or the presence of a tumor. Thus, tissue AST activity may become a novel marker of brain disorders which has been inaccessible using current clinical technologies. Applications and Market: Diagnosis and monitoring disease status in a variety of diseases, including Huntington’s Disease, olivopontocerebellar atrophy, epilepsy, schizophrenia, as well as hepatitis, cirrhosis, cholangitis, Gilbert’s diseases, muscular dystrophy, leukemia, kidney inflammation, cardiac infarction, or the presence of a tumor. The diagnostic market is a multi-billion dollar market, with a need for more efficient noninvasive techniques, markers and new methods of diagnosis. Patent Status: U.S. Patent Application No. 11/356,214 filed 21 Feb 2006 (HHS Reference No. E–231–2005/0–US–02). Inventors: Dr. Jun Shen (NIMH). Publication: J Shen. In vivo carbon-13 magnetization transfer effect: detection of aspartate aminotransferase reaction. Magn Reson Med. 2005 Dec; 54(6):1321– 1326. Licensing Status: Available for exclusive or non-exclusive licensing. Licensing Contact: Chekesha Clingman, Ph.D.; 301/435–5018; clingman@mail.nih.gov. Dated: August 29, 2006. Steven M. Ferguson, Director, Division of Technology Development and Transfer, Office of Technology Transfer, National Institutes of Health. [FR Doc. 06–7439 Filed 9–5–06; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health rwilkins on PROD1PC63 with NOTICES National Center for Complementary & Alternative Medicine; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the National Advisory Council for Complementary and Alternative Medicine, September 8, 2006, 9 a.m. to September 8, 2006, 4 p.m., National Institutes of Health, Neuroscience Building, 6001 Executive Boulevard, Rooms C & D, Rockville, MD 20852, which was published in the VerDate Aug<31>2005 18:44 Sep 05, 2006 Jkt 208001 Federal Register on July 28, 2006, 71 FR 42860. This meeting is being amended due to the start time change for the Open session from 2 p.m. to 1:30 p.m. The meeting is partially Closed to the public. Dated: August 28, 2006. Anna Snouffer, Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 06–7436 Filed 9–5–06; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institute of Mental Health; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Mental Health Special Emphasis Panel; NIMH Eating Disorders Grant Application Review. Date: September 29, 2006. Time: 1 p.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852, (Telephone Conference Call). Contact Person: Bettina D. Osborn, Ph.D., Scientific Review Administrator, Division of Extramural Activities, National Institute of Mental Health, National Institutes of Health, 6001 Executive Blvd., Room 6154, MSC 9609, Rockville, MD 20852–9609, 301–443–1178, acunab@mail.nih.gov. Name of Committee: National Institute of Mental Health Special Emphasis Panel; Mental Health Centers for Intervention Development and Applied Research (CIDAR). Date: October 12–13, 2006. Time: 9 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Bethesda Park Hotel, 8400 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: A. Roger Little, Ph.D., Scientific Review Administrator, Division of Extramural Activities, National Institute of Frm 00029 Fmt 4703 Sfmt 4703 Mental Health, National Institutes of Health, 6001 Executive Blvd., Room 6157, MSC 9609, Rockville, MD 20852–9609, 301–402–5844, alittle@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.242, Mental Health Research Grants; 93.281, Scientist Development Award, Scientist Development Award for Clinicians, and Research Scientist Award; 93.282, Mental Health National Research Service Awards for Research Training, National Institutes of Health, HHS) Dated: August 28, 2006. Anna Snouffer, Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 06–7434 Filed 9–5–06; 8:45 am] BILLING CODE 4140–01–M National Institutes of Health PO 00000 52551 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institutes of Diabetes and Digestive and Kidney Diseases; Amended Notice of Meeting Notice is hereby given of changes in the meeting of the National Diabetes and Digestive and Kidney Diseases Advisory Council, September 20, 2006, 8:30 a.m. to September 21, 2006, 12 p.m., National Institutes of Health, Building 31, 31 Center Drive, Bethesda, MD 20892, which was published in the Federal Register on August 18, 2006, 71 FR 47820–47821. Name of Committee: National Diabetes and Digestive and Kidney Diseases Advisory Council. Date: September 20–21, 2006. Open: September 20, 2006, 8:30 a.m. to 12 p.m. Agenda: To present the Director’s Report and other scientific presentations. Place: National Institutes of Health, Building 31, 31 Center Drive, Conference Room 10, Bethesda, MD 20892. Open: September 20, 2006, 4 p.m. to 5 p.m. Agenda: Report from the NIH Director. Place: National Institutes of Health, Building 31, 31 Center Drive, Conference Room 10, Bethesda, MD 20892. Closed: September 21, 2006, 9:45 a.m. to 10:15 a.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Building 31, 31 Center Drive, Conference Room 10, Bethesda, MD 20892. Open: September 21, 2006, 10:15 a.m. to 12 p.m. Agenda: Continuation of the Director’s Report and other scientific presentations. Place: National Institutes of Health, Building 31, 31 Center Drive, Conference Room 10, Bethesda, MD 20892. Contact Person: Brent B. Stanfield, Ph.D., Director, Division of Extramural Activities, National Institutes of Diabetes and Digestive and Kidney Diseases, 6707 Democracy Blvd., E:\FR\FM\06SEN1.SGM 06SEN1 rwilkins on PROD1PC63 with NOTICES 52552 Federal Register / Vol. 71, No. 172 / Wednesday, September 6, 2006 / Notices Rm. 715, MSC 5452, Bethesda, MD 20892, (301) 594–8843, stanfibr@niddk.nih.gov. Name of Committee: National Diabetes and Digestive and Kidney Diseases Advisory Council; Diabetes, Endocrinology, and Metabolic Diseases Subcommittee. Date: September 20–21, 2006. Open: September 20, 2006, 1 p.m. to 4 p.m. Agenda: To review the Division’s scientific and planning activities. Place: National Institutes of Health, Building 31, 31 Center Drive, Conference Room 10, Bethesda, MD 20892. Closed: September 21, 2006, 8 to 9:30 a.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Building 31, 31 Center Drive, Conference Room 10, Bethesda, MD 20892. Contact Person: Brent B. Stanfield, Ph.D., Director, Division of Extramural Activities, National Institutes of Diabetes and Digestive and Kidney Diseases, 6707 Democracy Blvd., Rm. 715, MSC 5452, Bethesda, MD 20892, (301) 594–8843, stanfibr@niddk.nih.gov. Name of Committee: National Diabetes and Digestive and Kidney Diseases Advisory Council; Digestive Diseases and Nutrition Subcommittee. Date: September 20–21, 2006. Closed: September 20, 2006, 1 p.m. to 2:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Building 31, 31 Center Drive, Conference Room 9A22, Bethesda, MD 20892 Open: September 20, 2006, 2:30 p.m. to 4 p.m. Agenda: To review the Division’s scientific and planning activities. Place: National Institutes of Health, Building 31, 31 Center Drive, Conference Room 9A22, Bethesda, MD 20892. Open: September 21, 2006, 8 a.m. to 9:30 a.m. Agenda: Continuation of the Division’s scientific and planning activities. Place: National Institutes of Health, Building 31, 31 Center Drive, Conference Room 9A22, Bethesda, MD 20892. Contact Person: Brent B. Stanfield, Ph.D., Director, Division of Extramural Activities, National Institutes of Diabetes and Digestive and Kidney Diseases, 6707 Democracy Blvd., Rm. 715, MSC 5452, Bethesda, MD 20892, (301) 594–8843, stanfibr@niddk.nih.gov. Name of Committee: National Diabetes and Digestive and Kidney Diseases Advisory Council; Kidney, Urologic, and Hematologic Diseases Subcommittee. Date: September 20–21, 2006. Open: September 20, 2006, 1 p.m. to 2:30 p.m. Agenda: To review the Division’s scientific and planning activities. Place: National Institutes of Health, Building 31, 31 Center Drive, Conference Room 9A22, Bethesda, MD 20892. Closed: September 20, 2006, 2:30 p.m. to 4 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Building 31, 31 Center Drive, Conference Room 9A22, Bethesda, MD 20892 VerDate Aug<31>2005 18:44 Sep 05, 2006 Jkt 208001 Open: September 21, 2006, 8 a.m. to 9:30 a.m. Agenda: Continuation of the Division’s scientific and planning activities. Place: National Institutes of Health, Building 31, 31 Center Drive, Conference Room 9A22, Bethesda, MD 20892. Contact Person: Brent B. Stanfield, Ph.D., Director, Division of Extramural Activities, National Institutes of Diabetes and Digestive and Kidney Diseases, 6707 Democracy Blvd., Rm. 715, MSC 5452, Bethesda, MD 20892, (301) 594–8843, stanfibr@niddk.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.847, Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive Diseases and Nutrition Research; 98.849, Kidney Diseases, Urology and Hematology Research, National Institutes of Health, HHS) Dated: August 28, 2006. Anna Snouffer, Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 06–7435 Filed 9–5–06; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HOMELAND SECURITY Agency Information Collection Activities: New Information Collection, Comment Request 30-day notice of information collection under review: CIS Ombudsman Case Problem Submission Worksheet, Form DHS–7001 (Previously published as Form G–1107). OMB Control No. 1615–NEW. ACTION: The Department of Homeland Security, Office of the Citizenship and Immigration Services (CIS) Ombudsman has submitted the following information collection request to the Office of Management and Budget (OMB) for review and clearance in accordance with the Paperwork Reduction Act of 1995. The information collection was previously published in the Federal Register on June 29, 2006, at 71 FR 37085. The notice allowed for a 60-day public comment period. No comments were received on this information collection. The purpose of this notice is to allow an additional 30 days for public comments. Comments are encouraged and will be accepted until October 6, 2006. This process is conducted in accordance with 5 CFR 1320.10. Written comments and/or suggestions regarding the item(s) contained in this notice, especially regarding the estimated public burden and associated response time, should be directed to the Department of Homeland Security (DHS), USCIS, Director, Regulatory PO 00000 Frm 00030 Fmt 4703 Sfmt 4703 Management Division, Clearance Office, 111 Massachusetts Avenue, 3rd floor, Washington, DC 20529. Comments may also be submitted to DHS via facsimile to 202–272–8352 or via e-mail at rfs.regs@dhs.gov. When submitting comments by e-mail please make sure to add DHS–7001 in the subject box. Written comments and suggestions from the public and affected agencies should address one or more of the following four points: (1) Evaluate whether the collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; (2) Evaluate the accuracy of the agency’s estimate of the burden of the collection of information, including the validity of the methodology and assumptions used; (3) Enhance the quality, utility, and clarity of the information to be collected; and (4) Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses. Overview of this information collection: (1) Type of Information Collection: New information collection. (2) Title of the Form/Collection: CIS Ombudsman Case Problem Submission Worksheet. (3) Agency form number, if any, and the applicable component of the Department of Homeland Security sponsoring the collection: DHS–7001. Office of the Citizenship and Immigration Services Ombudsman. (4) Affected public who will be asked or required to respond, as well as a brief abstract: Primary: Individuals or Households. This information collection is necessary for the CIS Ombudsman to identify problem areas, propose changes, and assist individuals experiencing problems during the processing of an immigration benefit with USCIS. (5) An estimate of the total number of respondents and the amount of time estimated for an average respondent to respond: 2,600 responses at 1 hour per response. (6) An estimate of the total public burden (in hours) associated with the collection: 2,600 annual burden hours. If you have comments, please submit them to DHS via facsimile to 202–272– 8352 or via e-mail at rfs.regs@dhs.gov, and to the DHS desk officer at: E:\FR\FM\06SEN1.SGM 06SEN1

Agencies

[Federal Register Volume 71, Number 172 (Wednesday, September 6, 2006)]
[Notices]
[Pages 52551-52552]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 06-7435]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institutes of Diabetes and Digestive and Kidney 
Diseases; Amended Notice of Meeting

    Notice is hereby given of changes in the meeting of the National 
Diabetes and Digestive and Kidney Diseases Advisory Council, September 
20, 2006, 8:30 a.m. to September 21, 2006, 12 p.m., National Institutes 
of Health, Building 31, 31 Center Drive, Bethesda, MD 20892, which was 
published in the Federal Register on August 18, 2006, 71 FR 47820-
47821.

    Name of Committee: National Diabetes and Digestive and Kidney 
Diseases Advisory Council.
    Date: September 20-21, 2006.
    Open: September 20, 2006, 8:30 a.m. to 12 p.m.
    Agenda: To present the Director's Report and other scientific 
presentations.
    Place: National Institutes of Health, Building 31, 31 Center 
Drive, Conference Room 10, Bethesda, MD 20892.
    Open: September 20, 2006, 4 p.m. to 5 p.m.
    Agenda: Report from the NIH Director.
    Place: National Institutes of Health, Building 31, 31 Center 
Drive, Conference Room 10, Bethesda, MD 20892.
    Closed: September 21, 2006, 9:45 a.m. to 10:15 a.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Building 31, 31 Center 
Drive, Conference Room 10, Bethesda, MD 20892.
    Open: September 21, 2006, 10:15 a.m. to 12 p.m.
    Agenda: Continuation of the Director's Report and other 
scientific presentations.
    Place: National Institutes of Health, Building 31, 31 Center 
Drive, Conference Room 10, Bethesda, MD 20892.
    Contact Person: Brent B. Stanfield, Ph.D., Director, Division of 
Extramural Activities, National Institutes of Diabetes and Digestive 
and Kidney Diseases, 6707 Democracy Blvd.,

[[Page 52552]]

Rm. 715, MSC 5452, Bethesda, MD 20892, (301) 594-8843, 
stanfibr@niddk.nih.gov.

    Name of Committee: National Diabetes and Digestive and Kidney 
Diseases Advisory Council; Diabetes, Endocrinology, and Metabolic 
Diseases Subcommittee.
    Date: September 20-21, 2006.
    Open: September 20, 2006, 1 p.m. to 4 p.m.
    Agenda: To review the Division's scientific and planning 
activities.
    Place: National Institutes of Health, Building 31, 31 Center 
Drive, Conference Room 10, Bethesda, MD 20892.
    Closed: September 21, 2006, 8 to 9:30 a.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Building 31, 31 Center 
Drive, Conference Room 10, Bethesda, MD 20892.
    Contact Person: Brent B. Stanfield, Ph.D., Director, Division of 
Extramural Activities, National Institutes of Diabetes and Digestive 
and Kidney Diseases, 6707 Democracy Blvd., Rm. 715, MSC 5452, 
Bethesda, MD 20892, (301) 594-8843, stanfibr@niddk.nih.gov.
    Name of Committee: National Diabetes and Digestive and Kidney 
Diseases Advisory Council; Digestive Diseases and Nutrition 
Subcommittee.
    Date: September 20-21, 2006.
    Closed: September 20, 2006, 1 p.m. to 2:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Building 31, 31 Center 
Drive, Conference Room 9A22, Bethesda, MD 20892
    Open: September 20, 2006, 2:30 p.m. to 4 p.m.
    Agenda: To review the Division's scientific and planning 
activities.
    Place: National Institutes of Health, Building 31, 31 Center 
Drive, Conference Room 9A22, Bethesda, MD 20892.
    Open: September 21, 2006, 8 a.m. to 9:30 a.m.
    Agenda: Continuation of the Division's scientific and planning 
activities.
    Place: National Institutes of Health, Building 31, 31 Center 
Drive, Conference Room 9A22, Bethesda, MD 20892.
    Contact Person: Brent B. Stanfield, Ph.D., Director, Division of 
Extramural Activities, National Institutes of Diabetes and Digestive 
and Kidney Diseases, 6707 Democracy Blvd., Rm. 715, MSC 5452, 
Bethesda, MD 20892, (301) 594-8843, stanfibr@niddk.nih.gov.

    Name of Committee: National Diabetes and Digestive and Kidney 
Diseases Advisory Council; Kidney, Urologic, and Hematologic 
Diseases Subcommittee.
    Date: September 20-21, 2006.
    Open: September 20, 2006, 1 p.m. to 2:30 p.m.
    Agenda: To review the Division's scientific and planning 
activities.
    Place: National Institutes of Health, Building 31, 31 Center 
Drive, Conference Room 9A22, Bethesda, MD 20892.
    Closed: September 20, 2006, 2:30 p.m. to 4 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Building 31, 31 Center 
Drive, Conference Room 9A22, Bethesda, MD 20892
    Open: September 21, 2006, 8 a.m. to 9:30 a.m.
    Agenda: Continuation of the Division's scientific and planning 
activities.
    Place: National Institutes of Health, Building 31, 31 Center 
Drive, Conference Room 9A22, Bethesda, MD 20892.
    Contact Person: Brent B. Stanfield, Ph.D., Director, Division of 
Extramural Activities, National Institutes of Diabetes and Digestive 
and Kidney Diseases, 6707 Democracy Blvd., Rm. 715, MSC 5452, 
Bethesda, MD 20892, (301) 594-8843, stanfibr@niddk.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.847, 
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive 
Diseases and Nutrition Research; 98.849, Kidney Diseases, Urology 
and Hematology Research, National Institutes of Health, HHS)

    Dated: August 28, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 06-7435 Filed 9-5-06; 8:45 am]
BILLING CODE 4140-01-M

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.